Skip to main content
OpenTrials

Clinical trial condition

Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type

Explore clinical trials studying Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type trial results

Active, Not Recruiting

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

NCT02520791

Conditions
Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +29 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 23 locations
View Trial Details

Related conditions